• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新时代镰状细胞病的循证牙科管理:范围综述。

Evidence-based dental management in the new era of sickle cell disease: A scoping review.

出版信息

J Am Dent Assoc. 2020 Sep;151(9):668-677.e9. doi: 10.1016/j.adaj.2020.05.023.

DOI:10.1016/j.adaj.2020.05.023
PMID:32854869
Abstract

BACKGROUND

Sickle cell disease (SCD) is an emerging global health issue with rapid progress in therapy especially since 2017. However, systematic reviews found no clinical trials on dental treatment of SCD.

TYPES OF STUDIES REVIEWED

Using a scoping review approach, the authors examined citations from 13 national SCD guidelines and 10 books spanning 4 decades. The authors also searched the following databases: PubMed, Cumulative Index to Nursing and Allied Health Literature, ScienceDirect, Scientific Electronic Library Online, and GoogleScholar. Eligibility criteria included SCD, oral health care and dental treatment, related to oral and systemic health, original data, or observations.

RESULTS

Systemic treatment of SCD might have opposing effects on caries, perhaps explaining the conflicting results published. Malocclusion correlates with marrow expansion. Other unusual orofacial findings reflect ischemia. Of 86 full-text articles examined, only 1, a Brazilian esthetic dentistry study, was a randomized clinical trial. No disease-specific data were found on risk of developing bacterial endocarditis, safety of inhaled nitrous oxide, safety of epinephrine with local anesthetic, or the benefit of comprehensive oral health care.

PRACTICAL IMPLICATIONS

In SCD, oral health and systemic health could be strongly linked. Penicillin, vaccines, and hydroxyurea might impact caries and bone. The interaction of SCD treatments and oral health merit study.

摘要

背景

镰状细胞病(SCD)是一个新兴的全球健康问题,尤其是自 2017 年以来,治疗方法取得了快速进展。然而,系统评价并未发现关于 SCD 牙科治疗的临床试验。

研究类型

作者采用范围综述方法,检查了 13 项国家 SCD 指南和 10 本跨越 40 年的书籍中的参考文献。作者还检索了以下数据库:PubMed、Cumulative Index to Nursing and Allied Health Literature、ScienceDirect、Scientific Electronic Library Online 和 Google Scholar。纳入标准包括 SCD、口腔保健和牙科治疗、与口腔和全身健康相关、原始数据或观察结果。

结果

SCD 的全身治疗可能对龋齿产生相反的影响,这也许可以解释发表的相互矛盾的结果。错颌畸形与骨髓扩张相关。其他不寻常的口腔颌面部发现反映了缺血。在 86 篇全文文章中,只有 1 篇巴西美学牙科研究是随机临床试验。未发现关于细菌心内膜炎风险、吸入一氧化二氮安全性、局部麻醉剂中肾上腺素安全性或全面口腔保健益处的特定疾病数据。

实际意义

在 SCD 中,口腔健康和全身健康可能密切相关。青霉素、疫苗和羟基脲可能会影响龋齿和骨骼。SCD 治疗和口腔健康的相互作用值得研究。

相似文献

1
Evidence-based dental management in the new era of sickle cell disease: A scoping review.新时代镰状细胞病的循证牙科管理:范围综述。
J Am Dent Assoc. 2020 Sep;151(9):668-677.e9. doi: 10.1016/j.adaj.2020.05.023.
2
Orofacial Manifestation and Dental Management of Sickle Cell Disease: A Scoping Review.镰状细胞病的口腔面部表现及牙科处理:一项范围综述
Anemia. 2021 Oct 22;2021:5556708. doi: 10.1155/2021/5556708. eCollection 2021.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2.
5
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.镰状细胞病的管理:专家小组成员 2014 年循证报告的总结。
JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517.
6
Orofacial manifestations in patients with sickle cell disease.镰状细胞病患者的口腔颌面部表现。
Am J Med Sci. 2013 Mar;345(3):234-7. doi: 10.1097/MAJ.0b013e318265b146.
7
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
8
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
9
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟基脲素)用于镰状细胞病。
Cochrane Database Syst Rev. 2017 Apr 20;4(4):CD002202. doi: 10.1002/14651858.CD002202.pub2.
10
Treatment of dental complications in sickle cell disease.镰状细胞病的牙科并发症治疗
Cochrane Database Syst Rev. 2019 Dec 16;12(12):CD011633. doi: 10.1002/14651858.CD011633.pub3.

引用本文的文献

1
Validating evidence for the knowledge, management and involvement of dentists in a dental approach to sickle-cell disease.验证牙医在镰状细胞病口腔治疗方法中的知识、管理和参与的证据。
Braz Oral Res. 2024 Apr 5;38:e026. doi: 10.1590/1807-3107bor-2024.vol38.0026. eCollection 2024.
2
Dental Caries in Children with Sickle Cell Disease and Its Association with the Use of Hydroxyurea and Penicillin Prophylaxis in Dar Es Salaam.达累斯萨拉姆镰状细胞病患儿的龋齿及其与羟基脲使用和青霉素预防的关联
Pediatric Health Med Ther. 2024 Mar 22;15:121-128. doi: 10.2147/PHMT.S443139. eCollection 2024.
3
Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy.
母胎医学协会咨询系列#68:妊娠期镰状细胞病
Am J Obstet Gynecol. 2024 Feb;230(2):B17-B40. doi: 10.1016/j.ajog.2023.10.031. Epub 2023 Oct 21.
4
Clinical Vignettes, Part II: Eyes, Teeth, and Bone.临床病例(二):眼睛、牙齿和骨骼。
Hematol Oncol Clin North Am. 2022 Dec;36(6):1201-1215. doi: 10.1016/j.hoc.2022.08.010.
5
Assessment of oral health condition in recipients of allogeneic hematopoietic cell transplantation.异基因造血细胞移植受者口腔健康状况评估。
Hematol Transfus Cell Ther. 2022 Oct-Dec;44(4):549-554. doi: 10.1016/j.htct.2021.02.009. Epub 2021 May 11.